Article info
PDFOriginal EBM Research
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
- Correspondence to Dr Slavka Baronikova, Shire International GmbH (now part of Takeda), Zug, Switzerland; slavka.baronikova{at}takeda.com
Citation
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Publication history
- Accepted March 4, 2019
- First published March 21, 2019.
Online issue publication
November 06, 2019
Article Versions
- Previous version (25 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.